/
؀̀ሀἀᰀ/̀ᜀ%ᜀ ؀̀ሀἀᰀ/̀ᜀ%ᜀ

؀̀ሀἀᰀ/̀ᜀ%ᜀ - PDF document

giovanna-bartolotta
giovanna-bartolotta . @giovanna-bartolotta
Follow
386 views
Uploaded On 2015-09-20

؀̀ሀἀᰀ/̀ᜀ%ᜀ - PPT Presentation

x0E00x1300x1E00x1F00x1B00 x1D00x1700x1A00x1B00x1800x1300x1200x1400x1300x1600x1F00x1500x1900 x1800x1F00x1600x1C00x1800x1300 ID: 134354

฀ጀḀἀ#ᬀ ᴀᜀᨀᬀ"᠀ጀሀ᐀ጀ"ᘀἀᔀᤀ ᠀ἀᘀᰀ᠀ጀ

Share:

Link:

Embed:

Download Presentation from below link

Download Pdf The PPT/PDF document "؀̀ሀἀᰀ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

؀̀ሀἀᰀ/̀ᜀ%ᜀᬀ ᜀ%/\t&2,%ᜀ#/&ᴀ/̀\fԀ/./\fᜀ5/17'1 ฀ጀḀἀ�#ᬀ ᴀ�ᜀᨀᬀ"᠀ጀሀ᐀ጀ�"ᘀἀᔀ�ᤀ ᠀ἀᘀᰀ᠀ጀȀᄀᔀᬀᘀᄀጀ�ᄀကḀጀḀ ᘀᴀḀ&Ā!#"'ᴀĀ,Ā\nĀᤀ᠀&ᬀ&଀ȀĀ ሀᬀᰀȀĀ\f%!ȀĀ᠀"ᨀĀ฀ᴀᬀ&'Ā᐀᠀$( ᬀ&\nĀԀȀ ̀Ā \f&+!$'#!᠀'ḀᤀĀጀ#&ᬀĀሀᬀ&Ḁ#"\nĀԀ̀ ЀĀ \r ᠀ᤀἀĀ᠀"ᨀĀᜀᴀḀ'ᬀĀ᐀᠀$( ᬀ&\nĀԀЀ ԀĀ ༀ ᬀ)᠀'ᬀᨀȀĀᘀ᠀"Ā฀# #(%ᬀᨀĀሀᬀ&Ḁ#"\nĀԀ؀ ؀Ā ᐀%(%Ḁ'ḀᤀȀĀ᐀(%$ ᬀĀ᐀᠀$( ᬀ&\nĀԀ܀ ܀Ā ᘀᴀᬀĀᔀᴀ+Āᘀ#ᬀ\nĀԀ\b \bĀ ᔀἀḀ"Ā฀# #(%ᬀᨀĀ\r(!$&\nĀԀ\t \tĀ ᄀ᠀"ᰀḀ"ᰀĀᔀἀḀ"Āက%#*'ᴀ&\nĀ؀Ȁ%/0:Āༀ\n܀@,(9܀63+Ā4(3,Ā/(:Ā),,5Ā,?7,90,5*05.Ā+,=,36705.Ā7(73,:Ā65Ā/0:Ā3,.:؀Ā(94:؀Ā(5+Ā*/,:;Ā6=,9Ā;/,7(:;Ā଀ༀĀ@,(9:\bĀ%/6:,Ā65Ā;/,Ā3,-;Ā;/0./Ā(9,Ā=063(*,6:؀.967,+؀Ā(5+Ā;,5+,9\bĀᬀ0:Ā46;/,9Ā/(:Ā:0403(9Ā3,:065:\bᬀ,Ā/(:Ā(Ā/0:;69@Ā6-Ā9,5(3Ā*(5*,9\b ༀᔀကἀ�ᘀḀ�#ᬀ ᴀ�ሀᘀက᐀ᨀᬀḀᘀḀ̀(\b ἀ3;073,Ā3,064@64(;( )\b ᨀ364:Ā;469: *\b ᐀5.064(;( +\b $7096(+,564(;( ,\b ᐀5.0630764(: ЀᨀḀ"ጀᴀ ἀ3;073,Ā3,064@64(;(ĀĀ̀܀\t\n؀\b�̀Ȁ(9,Ā),50.5Ā;469:(90:05.Ā-964Ā;/,Ā(99,*;69Ā7030Ā4:*3,:\bĀ%/,@Ā4(@Ā(3:6(90:,Ā05Ā+(9;6;0*؀Ā=3=(9؀Ā69Ā4(44033(9@Ā4:*3,\bἀ3;073,؀Ā*;(5,6:Ā3,064@64(;(Ā(9,Ā-094؀)96؀50:/Ā;6Ā=063(*,6:Ā7(73,:؀Ā9(5.05.Ā05Ā:0A,-964Ā\fĀ44Ā;6Ā\f\nĀ44؀Ā:05.3,Ā69Ā.967,+Ā65Ā;/,;952Ā(5+Ā,?;9,40;0,:\bĀἀ6:;Ā*644653@Ā;/,@Ā(77,(905Ā05+0=0+(3:ĀĀ/6Ā(9,଀\n܀Ā;6܀฀\n܀@,(9:܀6-܀(.,\bĀ%/0:Ā;@7,Ā0:Ā05/,90;,+Ā(:Ā(Ā+6405(5;Ā;9(0;\bĀ%/,9,0:Ā(Ā79,+0:76:0;065Ā;6Ā;@7,Ā\fĀ7(7033(9@Ā9,5(3Ā*(9*0564(ĀЀ#,,+̀:Ā$@5+964,Ԁ؀Ā(5+ĀĀ64,5Ā(9,Ā7965,Ā;6;,905,Ā3,064@64(;(\bἀ6:;Ā7(;0,5;:ĀĀ0;/Ā43;073,Ā3,064@64(;(Ā/(=,Ā(Ā4;(;065Ā05Ā;/,Ā-4(9(;,Ā/@+9(;(:,Ā.,5,\bĀ᐀:Ā;/,Ā3,:065:Ā(9,),50.5؀Ā;/,@Ā*(5Ā),Ā3,-;Ā(365,؀Ā,?*0:,+؀Ā69Ā()3(;,+Ā0-:@47;64(;0*Ā69Ā*6:4,;0*(33@Ā5(**,7;()3,\bĀ"(;0,5;:Ā0;/Ā43;073,Ā3,064@64(;(Ā:/63+Ā),Ā(7796790(;,3@*/,*2,+Ā-69Ā9,5(3Ā*(9*0564(Ā(:ĀĀ,33Ā(:Ā;,905,Ā3,064@64(;(Ā05ĀĀ64,5\b \nጀ᐀Ā�ЀᴀᤀĀ�ကᨀሀ�؀ᔀጀḀἀ�\fကᰀ ᠀ጀḀ \nကሀᄀ�Ā ᄀ0ᜀ%#ᰀ5/ᔀ %ᰀᨀ/\fЀᨀ/؀က̀ༀ̀ᨀ/ -/ᜀ/Ѐᰀ,$ᜀ0&#&Ḁ -0/ %/\r&,0ἀᘀ&,"ᨀ/฀%0ᜀ, &+ \f฀\r\tༀ\f ᐀Ā\rༀ܀@,(9܀63+܀4(3,Ā0:Ā56;,+Ā;6Ā/(=,Ā(Ā:;()3,؀Ā(:@47;64(;0*Ā3,:065Ā65Ā/0:Ā56:,Ā6-Ā6=,9Ā଀\n܀@,(9:Ā+9(;065\b ༀᔀကἀ�ᘀḀ�#ᬀ ᴀ�ሀᘀက᐀ᨀᬀḀᘀḀ̀(\b "@6.,50*Ā.9(5364( )\b ,=:Ā:,)(*,6: *\b ,=:Ā(5,40*: +\b ᤀ0)96:Ā7(73, ,\b ᔀ(:(3Ā*,33Ā*(9*0564(Ā ЀᨀḀ"ጀᴀ ᤀ0)96:Ā7(73,ĀĀ̀܀\t\n؀\b�ԀȀ0:Ā(Ā*64465؀Ā),50.5;469Ā6-Ā;/,Ā-(*,\bĀᰀ;Ā0:Ā),:;Ā*65:0+,9,+Ā;6Ā),Ā(Ā=(90(5;Ā6-Ā(5Ā(5.06-0)964(\bĀ"(;/636.@Ā9,=,(3:Ā(Ā79630-,9(;065Ā6-Ā+,5+90;0*Ā*,33:ĀĀ0;/05Ā-0)96:Ā;0::,\bĀĀᘀ3050*(3Ā,?(405(;065Ā+0:73(@:Ā(Ā;9(5:3*,5;܀܀/0;,7(73,ĀĀ0;/Ā(Ā:466;/Ā+64,Ā:/(7,+Ā:9-(*,Ā05Ā(Ā@65.(+3;Ā;6Ā40++3,Ā(.,+Ā7,9:65\bĀĀ%/,Ā4(1690;@Ā6-Ā3,:065:(9,Ā(:@47;64(;0*؀Ā(3;/6./Ā;/,9,Ā4(@Ā),Ā(Ā/0:;69@Ā6-)3,,+05.ĀĀ0;/Ā40569Ā;9(4(\bĀĀ%/,Ā46:;Ā*64465Ā:0;,Ā6-05=63=,4,5;Ā0:Ā;/,Ā56:,؀Ā(3;/6./Ā0;Ā4(@Ā6**9Ā,3:,Ā/,9,Ā65Ā;/,Ā-(*,Ā(5+Ā)6+@\bĀĀᤀ0)96:Ā7(73,;,5+:Ā;6),Ā:630;(9@Ā05Ā5(;9,Ā(5+Ā4,(:9,Ā3,::Ā;/(5ĀༀĀ44Ā05+0(4,;,9\b%/,Ā4(05Ā+0--,9,5;0(3Ā+0(.56:0:Ā0:Ā(Ā)(:(3Ā*,33Ā*(9*0564(ĀЀᔀᘀᘀԀ\bĀᔀᘀᘀĀ0:Ā*/(9(*;,90A,+Ā)@Ā9(70+Ā.96Ā;/Ā0;/Ā(Ā/0:;69@Ā6-Ā:765;(5,6:Ā)3,,+05.\bĀᤀ0)96:7(73,:4(@Ā),Ā9,46=,+Ā65Ā(Ā*6:4,;0*Ā)(:0:Ā69Ā+,Ā;6(Ā4,+0*(3Ā*65*,95Ā;6Ā93,Ā6;Ā;/,Ā76::0)030;@Ā6-Āᔀᘀᘀ\b$0473,Ā:/(=,Ā,?*0:065Ā0:Ā:--0*0,5;Ā-69Ā(Ā50*,Ā*6:4,;0*9,:3;\b ሀἀᰀ/̀ᜀ%ᜀᬀ ᜀ%/\t&2,%ᜀ#/&ᴀ/̀\fԀ/./\fᜀ5/17'1//؀Ѐ ᄀ $&%/଀ᰀᰀᨀ/\fЀᨀ/؀က̀ༀ̀ᨀ/ -/ᜀ/Ѐᰀ,$ᜀ0&#&Ḁ -0/4ἀ&/(,ᜀᤀ0 ᤀᰀ-/ %/က ᤀἀ$&%ᬀ/\b ##ᨀ/฀%0ᜀ, & ЀḀ#ᤀᰀἀᬀᤀကἀᘀᄀ�଀ᬀḀጀ�\nጀḀᘀᬀᨀ \nကሀᄀ�Ȁ \f฀\r\tༀ\f ؀Ԁሀἀᰀ/̀ᜀ%ᜀᬀ ᜀ%/\t&2,%ᜀ#/&ᴀ/̀\fԀ/./\fᜀ5/17'1 \f฀\r\tༀ\f \nကሀᄀ�̀ ᐀5Ā,0./;܀(5+܀(܀/(3-܀@,(9܀63+Ā.093Ā79,:,5;:ĀĀ0;/Ā(Ā305,(973(8,Ā6-ĀĀ/0;,Ā(5+Ā)3(*2Ā7(73,:Ā()6=,Ā;/,Ā3,-;5(:63()0(3Ā-63+\bĀĀᰀ;Ā/(:Ā),,5Ā79,:,5;Ā-69Ā(Ā@,(9\b ༀᔀကἀ�ᘀḀ�#ᬀ ᴀ�ሀᘀက᐀ᨀᬀḀᘀḀ̀(\b Ḁ0*/,5Ā:;90(;: )\b ᤀ(*0(3Ā(5.06-0)964(: *\b ἀ030( +\b ᐀*5,Ā=3.(90: ,\b ,=:Ā*64,+650*:ĀĀ ЀᨀḀ"ጀᴀ ,=:Ā*64,+650*:ĀĀ̀܀\t\n؀\b�؀Ȁ0:Ā(Ā9(9,Ā3,:065Ā6-Ā-6330*3(9Ā690.05\bĀᰀ;Ā0:Ā:(33@Ā79,:,5;Ā(;Ā)09;/Ā(5+Ā4(@),*64,Ā469,Ā,=0+,5;Ā+905.Ā;/,Ā-09:;Ā+,*(+,Ā6-Ā30-,\bĀᰀ;(77,(9:Ā(:Ā(Ā73(8,Ā*6476:,+Ā6-Ā/@7,92,9(;6;0*7(73,:Ā(5+Ā/695@Ā73.:Ā9,:,4)305.Ā;/,Ā*64,+65,:Ā6-(*5,Ā=3.(90:\bĀ%/,@Ā6-;,5Ā79,:,5;Ā05Ā(Ā305,(9Ā+0:;90);065\bĀ%/,Ā3,:065:Ā4(@Ā.0=,Ā;/,Ā;,?;9,Ā6-Ā;/,Ā:205Ā(.9(;,9܀302,Ā-,,305.\bĀ ,=:Ā*64,+650*:Ā;,5+:Ā;6Ā.96Ā05Ā796769;065ĀĀ0;/Ā;/,Ā(--,*;,+Ā*/03+\bĀἀ(5(.,4,5;Ā0:=,9@Ā*/(33,5.05.؀Ā(:Ā46:;Ā4,+0*(3Ā;/,9(70,:Ā(9,Ā05,--,*;0=,\bĀᜀ,-050;0=,Ā;/,9(7@Ā-69Ā*6:4,;0*(33@Ā:0.50-0*(5;Ā3,:065:Ā0:Ā:9.0*(3Ā,?*0:065\bĀᤀ(*0(3Ā(5.06-0)964(:Ā(9,Ā),50.5Ā+,94(3Ā5,673(:4:Ā;/(;Ā*65:0:;Ā6-Ā+,94(3Ā-0)9673(:0(Ā(5+Ā+03(;,+Ā)366+Ā=,::,3:\bĀἀ3;073,Ā-(*0(3Ā(5.06-0)964(:Ā(9,-9,8,5;3@Ā:,,5Ā05Ā7(;0,5;:ĀĀ0;/Ā;),96:Ā:*3,96:0:Ѐ(3:6Ā256Ā5Ā(:Ā(+,564(Ā:,)(*,4Ā*6473,?Ԁ؀Ā43;073,Ā,5+6*905,Ā5,673(:0(Ā;@7,Ā଀؀Ā(5+Āᔀ09;܀ᬀ6..܀ᜀ)DĀ:@5+964,\bĀḀ,:065:Ā6-Ā(+,564(Ā:,)(*,4Ā(9,+0:*9,;,؀Ā-094؀Ā9,++0:/Ā7(73,:Ā;/(;Ā-9,8,5;3@Ā+,=,367Ā05Ā;/,Ā5(:63()0(3Ā-63+:Ā+905.Ā3(;,Ā*/03+/66+;6Ā,(93@Ā(+63,:*,5*,؀Ā05*9,(:05.Ā05Ā:0A,Ā(5+Ā54),9+905.Ā7),9;@\bĀ%/,:,Ā4(@Ā),Ā9,46=,+Ā)@Ā3(:,9;9,(;4,5;\bĀḀ0*/,5Ā:;90(;:Ā0:Ā(Ā:,3-܀3040;05.Ā+,94(;0;0:Ā;/(;Ā79,:,5;:ĀĀ0;/Ā(Ā503(;,9(3܀*9=0305,(9Ā*633,*;065Ā6-Ā:4(33؀Ā,9@;/,4(;6:؀Ā-3(;܀;677,+Ā7(73,:Ā;/(;Ā-6336Āᔀ3(:*/26̀:Ā305,:ĀЀ;/,Ā7(;/Ā6-Ā,*;6+,94(3Ā,4)9@636.0*+,=,3674,5;Ā6-Ā:205Ԁ\bĀ%/,Ā4,(5Ā(.,Ā6-Ā65:,;Ā0:Ā-69܀@,(9:܀6-܀(.,؀Ā(5+Ā.093:Ā(9,Ā;Ā6܀;6܀;/9,,܀;04,:Ā469,Ā-9,8,5;3@Ā(--,*;,+Ā;/(5Ā)6@:\bĀἀ6:;Ā*644653@؀Ā0;(--,*;:Ā;/,Ā,?;9,40;0,:\bĀ%/,Ā3,:065:Ā(9,Ā:(33@Ā(:@47;64(;0*Ā(5+Ā9,:63=,Ā:765;(5,6:3@ĀĀ0;/05Ā\rĀ;6Ā\f฀465;/:ĀЀЀ0;/Ā(Ā4,(5Ā+9(;065Ā6-Ā:0?Ā465;/:Ԁ\bĀἀ030(Ā(9,Ā:4(33Ā9,;,5;065Ā*@:;:Ā*644653@Ā:,,5Ā65;/,Ā-(*,:Ā6-Ā5,Ā)695:\bĀ%/,@Ā9,:3;Ā-964Ā9,;,5;065Ā6-2,9(;05ĀĀ0;/05Ā;/,Ā+,940:Ā(5+Ā(77,(9Ā(:Ā;05@Ā଀Ā;6Ā\fĀ447,(93@ĀĀ/0;,Ā69Ā@,336ĀĀ7(73,:\bĀ%/,@Ā(9,Ā46:;Ā796405,5;Ā65Ā;/,Ā*/,,2:؀Ā56:,؀Ā*/05؀Ā(5+Ā-69,/,(+\bĀἀ030(Ā:(33@Ā+0:(77,(9Ā)@Ā;/,Ā-09:;Ā;/9,,Ā;6Ā-69ĀĀ,,2:Ā6-Ā30-,Ā(5+9,809,Ā56Ā;/,9(7@\bĀ$,*65+(9@Ā4030(Ā4(@Ā(3:6Ā6**9Ā-6336Ā05.Ā)30:;,905.Ā69Ā;9(4(Ā(5+Ā(3:6Ā05Ā*,9;(05Ā79,+0:76:05.Ā*65+0;065:؀Ā:*/Ā(:Ā)336:Ā7,47/0.60+؀05/,90;,+Ā(5+Ā(*809,+Ā,70+,9463@:0:Ā)336:(؀Ā)336:30*/,5Ā73(5:؀Ā7697/@90(Ā*;(5,(Ā;(9+(؀Ā(5+Ā)95:\b&(90(5;:Ā6-Ā4030(Ā05*3+,Ā4030(Ā,5Ā73(8,Ā(5+Ā43;073,,97;0=,Ā4030(\b᐀*5,Ā=3.(90:Ā0:Ā(5Ā,?;9,4,3@Ā*64465Ā+0:,(:,Ā(5+0:Ā*/(9(*;,90A,+Ā)@Ā56505-3(44(;69@؀Ā67,5Ā69Ā*36:,+*64,+65,:Ā(5+Ā)@Ā05-3(44(;69@Ā7(73,:؀Ā7:;3,:؀Ā(5+56+3,:\bĀ᐀*5,Ā=3.(90:Ā(--,*;:Ā;/,Ā(9,(:Ā6-Ā:205ĀĀ0;/Ā;/,+,5:,:;Ā7673(;065Ā6-Ā:,)(*,6:Ā-6330*3,:؀Ā05*3+05.Ā;/,-(*,؀Ā;/,Ā77,9Ā7(9;Ā6-Ā;/,Ā*/,:;؀Ā(5+Ā;/,Ā)(*2\bĀ Ԁ᠀ကᄀᜀ�ကᨀሀ�ༀᔀᘀἀጀ�\fကᰀ ᠀ጀḀ \tᜀᤀ"/̀ἀᜀ%Ḁ/ -/ᜀ/ᴀ %ᜀ#/5ᰀᜀ,/\fᰀᬀ ᤀᜀ#/ᄀ02ᬀᰀ%0/ᜀ0/0ἀᰀ/ጀ% 3ᰀ,- 05&ᴀ/Ȁ, 0 -ἀ/̀$᠀ ᜀᨀ/᐀ᜀ%ᤀ&23ᰀ,ᨀ/Ȁ, 0 -ἀ/̀$᠀ ᜀ+\t&-ᰀ(ἀ/\f+/଀ᜀ$/ -/ᜀ/̀# % ᤀᜀ#/Ā-- -0ᜀ%0/ༀ,&ᴀᰀ--&,/&ᴀༀᜀᰀᬀ ᜀ0, ᤀ-/ᜀ%ᬀ/Ā--&ᤀ ᜀ0ᰀ/\fᰀ$᠀ᰀ,/&ᴀ/0ἀᰀ/Ѐᰀ(ᜀ,0$ᰀ%0/&ᴀЀᰀ,$ᜀ0&#&Ḁ5/ᜀ%ᬀ/ᄀ" %/ᄀᤀ ᰀ%ᤀᰀ-/ᜀ0/0ἀᰀ/ጀ% 3ᰀ,- 05/&ᴀ/Ȁ, 0 -ἂ$᠀ ᜀ+/\bᰀ/(,ᜀᤀ0 ᤀᰀ-/ %/᐀ᜀ%ᤀ&23ᰀ,ᨀ/Ȁ, 0 -ἀ/̀$᠀ ᜀ+ ؀܀ሀἀᰀ/̀ᜀ%ᜀᬀ ᜀ%/\t&2,%ᜀ#/&ᴀ/̀\fԀ/./\fᜀ5/17'1 \f฀\r\tༀ\f %/0:Ā3,:065ĀĀ(:Ā+,;,*;,+Ā+905.Ā;/0:Ā4(5̀:Ā@,(93@Ā7/@:0*(3\bĀ%/6./Ā/,ĀĀ(:Ā56;Ā*65*,95,+Ā()6;Ā0;؀Ā(:Ā/,Ā/(:/(+Ā0;Ā-69Ā()6;Ā଀\nĀ@,(9:Ā56Ā؀Ā/,Ā+0+؀Ā/6Ā,=,9؀ĀĀ0:/Ā;6256ĀĀĀ/(;Ā;/,Ā3,:065Ā*63+Ā),Ā:@4;64(;0*Ā6-\b ༀᔀကἀ�ᘀḀ�#ᬀ ᴀ�ሀᘀက᐀ᨀᬀḀᘀḀ̀(\b ᴀ,9(;6(*(5;/64( )\b ᔀ(:(3Ā*,33Ā*(9*0564( *\b ᬀ@7,9;67/0*Ā30*/,5Ā73(5: +\b $,)699/,0*Ā2,9(;6:0: ЀᨀḀ"ጀᴀ $,)699/,0*Ā2,9(;6:0:ĀĀ̀܀\t\n؀\b�ԀȀЀ(3:6Ā256Ā5Ā(:Ā:,)699/,0*Ā=,99*(؀Ā:,503,Ā2,9(;6:0:؀Ā(5+Ā:,503,ĀĀ(9;ԀĀ0:Ā(Ā565*(5*,96:Ā),50.5Ā:205Ā.96Ā;/Ā;/(;Ā690.05(;,:Ā05Ā2,9(;056*@;,:\bĀ$,)699/,0*Ā2,9(;6:,:Ā(9,Ā:,,5Ā469,Ā6-;,5Ā05(.05.Ā7,9:65:\bĀᰀ5Ā-(*;؀Ā;/,@Ā(9,Ā:64,;04,:Ā/4696:3@9,-,99,+Ā;6Ā(:ĀB;/,Ā)(95(*3,:Ā6-Ā63+Ā(.,\bCĀ$,)699/,0*Ā2,9(;6:,:Ā(9,Ā),50.5؀Ā);Ā:,*65+(9@;469:؀Ā/6Ā,=,9؀Āᔀ6ᔀ,5̀:Ā+0:,(:,ĀЀ:8(46:Ā*,33Ā*(9*0564(Ā05Ā:0;ԀĀ69Ā4(30.5(5;Ā4,3(564(Ā4(@Ā6**(:065(33@Ā(90:,ĀĀ0;/05Ā;/,Ā3,:065\bĀ$,)699/,0*Ā2,9(;6:,:Ā*(5(3:6Ā*(;*/Ā65Ā*36;/05.Ā(5+Ā),*64,Ā0990;(;,+\bĀ%/,@Ā*(50;*/؀Ā.96Ā؀Ā(5+Ā)3,,+\bĀ%/,@Ā(77,(9Ā05Ā=(906:Ā*6369:؀Ā-964Ā30./;Ā;(5Ā;6)3(*2\bĀ%/,@Ā(9,Ā965+Ā69Ā6=(3؀Ā-,,3Ā-3(;Ā69Ā:30./;3@Ā,3,=(;,+ĀЀ302,Ā;/,Ā:*()Ā-964Ā(Ā/,(305.ĀĀ65+Ԁ؀Ā(5+Ā9(5.,05Ā:0A,Ā-964Ā=,9@Ā:4(33Ā;6Ā469,Ā;/(5Ā\f\bༀĀ*4Ā(*96::\b%/,@Ā*(5Ā9,:,4)3,ĀĀ(9;:؀Ā;/6./Ā;/,@Ā+6Ā56;Ā/(=,Ā(=09(3Ā690.05\bĀ%/,@Ā*(5Ā(3:6Ā9,:,4)3,Ā4,3(564(Ā:205*(5*,9؀Ā;/6./Ā;/,@Ā(9,Ā59,3(;,+Ā;6Ā4,3(564(Ā(:ĀĀ,33\bᔀ,*(:,Ā653@Ā;/,Ā;67Ā3(@,9:Ā6-Ā;/,Ā,70+,940:Ā(9,05=63=,+؀Ā:,)699/,0*Ā2,9(;6:0:Ā(9,Ā6-;,5Ā+,:*90),+Ā(:/(=05.Ā(ĀB7(:;,+Ā65CĀ(77,(9(5*,\bĀ$64,Ā+,94(;636.0:;:9,-,9Ā;6Ā:,)699/,0*Ā2,9(;6:0:Ā(:ĀB:,)699/,0*ĀĀ(9;:ጀC/6ጀ,=,9؀Ā;/,:,Ā3,:065:Ā(9,Ā:(33@Ā56;Ā(::6*0(;,+ĀĀ0;/ᬀ"&؀Ā(5+؀Ā;/,9,-69,؀Ā:*/Ā564,5*3(;9,Ā:/63+Ā),Ā+0:*69(.,+\bᨀ,5,9(33@؀Ā;/,Ā;9,(;05.Ā7/@:0*0(5Ā:/63+Ā9,(::9,Ā;/,7(;0,5;Ā6-Ā;/,Ā),50.5Ā5(;9,Ā6-Ā;/,:,Ā3,:065:؀Ā/6Ā,=,9؀),*(:,Ā;/,@Ā*(5Ā),ĀĀ5:0./;3@؀Ā;/,9,Ā(9,Ā:64,Ā;9,(;4,5;67;065:Ā(=(03()3,Ā;6Ā(4,3069(;,Ā;/,09Ā(77,(9(5*,\bᴀ,;6*65(A63,Ā*9,(4Ā*(5Ā),Ā(7730,+Ā;Ā0*,Ā+(03@؀Ā2,;6*65(A63,Ā;()3,;:Ā\f\n\nĀ4.Ā8\b+\bĀ-69ĀᄀĀ;6Ā଀฀Ā+(@:Ā*(5Ā),;90,+Ā(:ĀĀ,33\bĀḀ6ḀĀ76;,5*@Ā.3*6*69;0*60+Ā*9,(4:Ā*(5.0=,Ā=,9@Ā.66+Ā9,:3;:ጀĀ;/,Ā3,:065:Ā*(5Ā(3:6Ā),Ā:9.0*(33@Ā9,46=,+\b ܀᠀ጀ!ကἀጀሀĀ�฀ကᨀ�؀ᬀ᠀ᬀ ᴀጀሀ�\nጀḀᘀᬀᨀ \nကሀᄀ�Ѐ \bᜀ5ᬀᰀ,/\n2᠀᠀ᜀᨀ/\fȀ̀ἀȀᨀ/଀\f̀̀ᨀ/̀̀؀ༀᨀ/؀က̀ᄀ)ጀ\n*ᨀЀ؀؀ༀᨀ/ЀༀЀᨀ/Ḁ,ᜀᬀ2ᜀ0ᰀᬀ/ᴀ,&$/0ἀᰀ/ጀ% 3ᰀ,- 05/&ᴀ/ȀᜀḀἀᬀᜀᬀᨀ4ἀᰀ,ᰀ/ἀᰀ/ % 0 ᜀ##5/0,ᜀ %ᰀᬀ/ᜀ-/ᜀ/ሀ,ᜀ2$ᜀ/ᄀ2,Ḁᰀ&%+/\bᰀ$&3ᰀᬀ/0&/Ȁ, 0ᜀ %ᨀ/4ἀᰀ,ᰀ/ἀᰀ/,ᰀᤀᰀ 3ᰀᬀ/ἀ -/؀က̀ᄀ/ᜀ%ᬀ4&,"ᰀᬀ/ᜀ-/ᜀ%/Ԁက/ༀἀ5- ᤀ ᜀ%/᠀ᰀᴀ&,ᰀ/-(ᰀᤀ ᜀ# 6 %Ḁ/ %/؀ᜀ$ #5\fᰀᬀ ᤀ %ᰀ+/\bᰀ/ -/ᤀ2,,ᰀ%0#5/ᜀ/؀ᜀ$ #5/ༀ,ᜀᤀ0 0 &%ᰀ,/ %\f -- --ᜀ2Ḁᜀᨀ/฀%0ᜀ, &+ ሀἀᰀ/̀ᜀ%ᜀᬀ ᜀ%/\t&2,%ᜀ#/&ᴀ/̀\fԀ/./\fᜀ5/17'1//؀\b \f฀\r\tༀ\f ᐀Ā฀\r܀@,(9܀63+؀Ā6=,9Ā,0./;Ā-,4(3,Ā79,:,5;:ĀĀ0;/Ā7990;0*؀Ā7973,Ā7(73,:Ā65Ā/,9Ā:/05:Ā(5+ĀĀ90:;:\b ༀᔀကἀ�ᘀḀ�#ᬀ ᴀ�ሀᘀက᐀ᨀᬀḀᘀḀ̀(\b Ḁ0*/,5Ā73(5: )\b ":;3(9Ā7:690(:0: *\b 443(9Ā,*A,4( +\b "0;@90(:0:Ā96:,( ,\b Ḁ0*/,5Ā:0473,?Ā*/9650*: ЀᨀḀ"ጀᴀ Ḁ0*/,5Ā73(5:ĀĀ̀܀\t\n؀\b�̀Ȁ0:Ā(Ā-(093@Ā*64465؀Ā7990;0*؀05-3(44(;69@Ā+0:,(:,Ā6-Ā5256∀5Ā,;0636.@\bĀ%/,:,3,:065:Ā(9,Ā*/(9(*;,90:;0*(33@Ā:4(33؀Ā=063(*,6:؀Ā-3(;܀;677,+؀Ā763@.65(3Ā7(73,:\bĀ%/,@Ā79,+6405(5;3@Ā(--,*;;/,Ā:205Ā(5+Ā*(5Ā(3:6Ā(--,*;Ā;/,Ā/(09Ā-6330*3,:؀Ā4*6:4,4)9(5,:؀Ā(5+Ā5(03:ĀЀༀĀ;6Ā଀\nȀԀ\bĀ!5Ā;/,Ā:9-(*,Ā6-:64,Ā3,:065:؀Ā.9,@Ā69ĀĀ/0;,Ā:;9,(2:Ā4(@Ā),Ā56;,+Ѐ'0*2/(4̀:Ā:;90(,Ԁ؀Ā(3;/6./Ā;/0:Ā0:Ā46:;Ā*644653@:,,5Ā65Ā;/,Ā4*6:Ā4,4)9(5,:\bĀᰀ;Ā/(:Ā(Ā79,+03,*;065-69Ā;/,Ā-3,?69ĀĀ90:;:؀Ā:/05:؀Ā(523,:؀Ā(5+Ā.3(5:Ā7,50:\bĀḀ0*/,5Ā73(5:Ā0:Ā(Ā*3050*(3Ā+0(.56:0:؀Ā(3;/6./Ā(Ā)067:@Ā0:Ā:64,;04,:Ā5,,+,+Ā-69Ā*65-094(;065\bĀᰀ;Ā0:*65:0+,9,+Ā(Ā:,3-܀3040;,+Ā+0:,(:,؀Ā6-;,5Ā9,:63=05.ĀĀ0;/05Ā଀\nĀ;6Ā଀ༀĀ465;/:\bĀἀ03+Ā;6Ā46+,9(;,Ā*(:,:Ā*(5Ā),Ā4(5(.,+ĀĀ0;/Ā46+,9(;,Ā;6Ā76;,5;Ā;670*(3Ā:;,960+:\bĀἀ69,:,=,9,Ā69Ā.,5,9(30A,+Ā05=63=,4,5;Ā*(5Ā),Ā;9,(;,+ĀĀ0;/7/6;6;/,9(7@Ā(5+Ā05Ā:64,Ā*(:,:ĀĀ0;/Ā:@:;,40*Ā:;,960+:69Ā69(3Ā9,;0560+:\bĀ \fᴀ ᴀᘀἀᘀᄀĀ�\f ᴀᰀ᠀ጀ�\fကᰀ ᠀ጀḀ \nကሀᄀ�Ԁ Ȁᰀ%!ᜀ$ %/Ȁᜀ,ᜀ%" %ᨀ/\fЀᨀ/؀က̀ༀ̀ᨀ/ -/ᜀ/Ѐᰀ,$ᜀ0&#&Ḁ -0(,ᜀᤀ0 ᤀ %Ḁ/ %/\r&,0ἀ/ᘀ&,"ᨀ/฀%0ᜀ, &+ ؀\tሀἀᰀ/̀ᜀ%ᜀᬀ ᜀ%/\t&2,%ᜀ#/&ᴀ/̀\fԀ/./\fᜀ5/17'1 \f฀\r\tༀ\f ᐀5Ā()5694(30;@Ā6-Ā(5Ā05-(5;Ā4(3,̀:Ā;6,Ā0:Ā56;0*,+Ā+905.Ā(Ā96;05,Ā=0:0;Ā;6Ā;/,Ā*3050*\b ༀᔀကἀ�ᘀḀ�#ᬀ ᴀ�ሀᘀက᐀ᨀᬀḀᘀḀ̀(\b $@5+(*;@3@ )\b ᘀ65.,50;(3Ā*93@Ā;6,ĀЀ*3056+(*;@3@Ԁ *\b ᘀ3)Ā-66; +\b 694(3Ā=(90(;065 ЀᨀḀ"ጀᴀ ᘀ65.,50;(3Ā*93@Ā;6,ĀĀ̀܀\t\n؀\b�ЀȀ0:Ā(Ā*65+0;065Ā6-Ā(55+,93(7705.Ā;6,\bĀᘀ644653@Ā05=63=,+Ā;6,:Ā(9,Ā;/,;/09+؀Ā-69;/؀Ā69Ā-0-;/Ā;6,:Ā6-Ā)6;/Ā-,,;\bĀ᐀3;/6./Ā;/,,?(*;Ā*(:,Ā6-Ā;/0:Ā*65+0;065Ā0:Ā5256�5؀Ā0;Ā;,5+:Ā;6-6336ĀĀ(Ā-(4030(3Ā7(;;,95\bĀᘀ/60*,Ā6-Ā;9,(;4,5;Ā+,7,5+:Ā65Ā;/,Ā+,.9,,Ā6-Ā;/,+,-6940;@؀Ā79,:,5*,Ā6-Ā:@47;64:؀Ā(5+Ā(.,Ā6-Ā;/,*/03+\bĀᰀ-Ā;/,Ā7(;0,5;̀:Ā:@47;64:Ā(9,Ā40504(3؀Ā;/,Ā(0;܀(5+܀:,,Ā(7796(*/Ā0:Ā9,*644,5+,+\bĀᰀ-Ā:9.,9@0:Ā05+0*(;,+؀Ā;/,Ā73(:;0*Ā:9.,65ĀĀ033Ā9,3,(:,Ā;/,Ā;,5+65Ā05Ā;/,Ā)6;;64Ā6-Ā;/,Ā;6,Ā-69Ā-3,?0)3,Ā+,-6940;@\bĀ#,46=(3Ā6-Ā(Ā:4(33Ā769;065Ā6-Ā;/,Ā;6,Ā40./;Ā),5,*,::(9@\bĀ ฀ᔀጀ�\rᔀ#�฀ᬀጀ \nကሀᄀ�؀ ̀ἀᰀ, %ᰀ0/ᄀᰀ ᬀᨀ/\fЀᨀ/଀\f̀̀ᨀ/̀̀؀ༀᨀ/Ѐሀ\f/)က̀ༀᄀ/܀#ᜀ-*ᨀ -/0ἀᰀ/଀ᰀᜀᬀ/ༀἀ5- ᤀ ᜀ%/&ᴀ/0ἀᰀ/\r&,0ἀ/ကᰀ%ᴀ,ᰀ4/؀ᜀ$ #5/\bᰀᜀ#0ἀሀᰀᜀ$ᨀ/Ѐᰀᰀ(/က 3ᰀ,ᨀ/฀%0ᜀ, &ᨀ/Ԁ$ᰀ,Ḁᰀ%ᤀ5/ༀἀ5- ᤀ ᜀ%/ᜀ0/Ѐᰀᰀ(က 3ᰀ,/ᜀ%ᬀ/Ѐ -0, ᤀ0/\b&-( 0ᜀ#ᨀ/ᜀ%ᬀ/Ā-- -0ᜀ%0/ༀ,&ᴀᰀ--&,/ᜀ0\r&,0ἀᰀ,%/฀%0ᜀ, &/ᄀᤀἀ&&#/&ᴀ/\fᰀᬀ ᤀ %ᰀᨀ/ᄀ2ᬀ᠀2,5ᨀ/฀%0ᜀ, &+ rhinitis, AVAMYSreduced Total Nasal Symptom Scores rTNSSrTNSSTotal Ocular Symptom Scores (rTOSS) vs. placebo..Reductions in daily rTNSS: AVAMYS-4.94 vs. lacebo -3.18, reductions in daily rTOSS: VAMYS-3.00 vs. placebo -2.26, VAMYSymptoms in patients 12 years of age and older and or the treatment of seasonal and perennial allergic hinitis in pediatric patients 2 to . VAMYSis contraindicated in patients with a hyper-sensitivity to any of its ingredients.The most common adverse events observed in adults/dolescents with seasonal or perennial allergic rhinitis treated with AVAMYSere:9%/8%9%/8%8%/5%8%/5% 3%/1%3%/1% nasal septum 1%/1%/2%/2%2%/2% 1%/1%/ upper respiratory tract infection1%/1%1%/1%1%/1%/ In a 1-year study n adults/adolescents, adverse events were similar n type and rate between AVAMYSand placebo. roup receiving AVAMYS vs. placebo (20% vs. 8%, espectively) and was of mild intensity in the majorityof patients (AVAMYS: 83/123; placebo: 17/17).The most common adverse events observed in childrenwith AVAMYS 55 mcg/AVAMYS 110 mcg/placebo were:8%/8%/7%8%/8%/7% nasopharyngitis 5%/5%/5%5%/5%/5%5%/4%/4%5%/4%/4% pyrexia 5%/4%/2%5%/4%/2%4%/3%/3%4%/3%/3% 3%/4%/3%3%/4%/3%3%/2%/3%3%/2%/3%Avoid use in patients with recent nasal ulcers, nasal surgery, or nasal trauma. There is no evidence of HPA axis suppression following12 months12 monthsAVAMYSWhen intranasal steroids are used at higher than recommended dosages or in susceptible individuals at recommended dosages, systemic corticosteroid effects may occur such as hypercorticism, suppressionof HPA function, and/or reduction of growth velocity in children or teenagers. A phase IV clinical trial to evaluate the effect of AVAMYSgrowth in pediatric patients. Physicians should closelymonitor the growth of children taking corticosteroids.metabolized by CYP3A4, co-administration with ritonavir is not recommended. and new infections may appear. Potential worsening of existing tuberculosis; fungal, bacterial, viral, or parasitic infections; or ocular herpes simplex may occur. Nasal and inhaled corticosteroids may result in the development of glaucoma and/or cataracts. Close monitoring is warranted in patients with a change pressure, glaucoma, and/or cataracts.* Study #FFR103184. A 2-week, randomized, double-blind, parallel-group, multicentre, placebo-controlled studycomparing AVAMYS=141) vs. placebo (=144) in patients with seasonal allergic rhinitis. REFERENCE: 1. Product Monograph of AVAMYS. GlaxoSmithKline Inc. September, 2011. AVAMYSby GlaxoSmithKline Inc. © 2012 GlaxoSmithKline Inc. All rights reserved. See prescribing summary Magenta, Yellow, Black CMYK Up to Date Up to Date Proven performance in allergic rhinitis. ؀\nሀἀᰀ/̀ᜀ%ᜀᬀ ᜀ%/\t&2,%ᜀ#/&ᴀ/̀\fԀ/./\fᜀ5/17'1 \f฀\r\tༀ\f ᐀Ā଀က܀465;/܀63+Ā.093Ā79,:,5;:ĀĀ0;/Ā:205Ā*6369,+7(73,:Ā6=,9Ā;/,Ā3,-;Ā(?033(,Ā(5+Ā;952Ā6-Ā-0=,܀܀,,2:+9(;065\bĀĀ ༀᔀကἀ�ᘀḀ�#ᬀ ᴀ�ሀᘀက᐀ᨀᬀḀᘀḀ̀(\b ᠀97;0=,Ā=,33:Ā/(09Ā*@:;: )\b "(73(9Ā9;0*(90( *\b ᰀ47,;0.6 +\b ἀ633:*4Ā*65;(.06:4Ā ,\b ᤀ6?܀ᤀ69+@*,Ā+0:,(:,Ā ЀᨀḀ"ጀᴀ ἀ633:*4Ā*65;(.06:4ĀĀ̀܀\t\n؀\b�ԀȀ؀Ā*(:,+Ā)@Ā(4,4),9Ā6-Ā;/,Ā76?=09:Ā-(403@؀Ā79,:,5;:ĀĀ0;/:466;/؀Ā:205Ā*6369,+؀Ā+64,Ā:/(7,+Ā7(73,:Ā(5+Ā0:*64465Ā05Ā*/03+9,5\bĀ%/,Ā3,:065:Ā*(5Ā9(5.,Ā-964Ā\fĀ;6ĀሀĀ44Ā(5+Ā4(@Ā*65;(05Ā(Ā:4(33Ā*,5;9(3Ā+,79,::065Ā;/(;Ā/6:,:Ā;/,Ā=09(3Ā)6+0,:\bĀ%/,Ā7(73,:Ā:(33@Ā79,:,5;Ā05Ā*3:;,9:Ā(5+Ā6**(:065(33@Ā05Ā305,(9Ā*65-0.9(;065:؀Ā+,Ā;6Ā26,)5,90A(;065\bĀ%/0:Ā05-,*;065:79,(+:Ā-964Ā:205܀;6܀:205Ā*65;(*;؀Ā:(33@Ā05Ā(9,(:Ā/,9,Ā9))05.Ā6**9:\bĀĀ$64,Ā*/03+9,5Ā4(@Ā(3:6Ā79,:,5;ĀĀ0;/Ā(Ā9,+؀Ā:*(3@Ā+,94(;0;0:Ā:9965+05.Ā;/,7(73,:؀ĀĀ/0*/Ā*(5Ā),Ā0;*/@\bĀĀἀ633:*4Ā0:Ā:,3-܀3040;05.Ā(5+Ā:765;(5,6:3@Ā*3,(9:Ā6=,9Ā;/,Ā@,(9:\bᘀ64465Ā05;,9=,5;065:Ā;6Ā,?7,+0;,Ā*3,(9(5*,Ā-69*6:4,;0*Ā7976:,:Ā05*3+,Ā;670*(3Ā;9,;05605Ā*9,(4؀*(5;/(90+05Ā)30:;,905.Ā(.,5;ĀЀ6--܀3(),3Ā:,Ԁ؀0408046+Ā*9,(4؀Ā*9@6;/,9(7@؀Ā(5+Ā*9,;;(.,\b᐀3;/6./Ā,97;0=,Ā=,33:Ā/(09Ā*@:;:Ā(9,Ā:0403(9Ā05(77,(9(5*,Ā;6Ā4633:*4؀Ā/(09Ā*@:;:Ā(9,Ā6-;,5/@7,970.4,5;,+Ā(5+Ā(9,Ā*644653@Ā-65+Ā65Ā;/,(5;,9069Ā*/,:;\bĀ%/,Ā3,:065:Ā(9,Ā*647(9(;0=,3@Ā:4(33,9Ā05Ā:0A,؀Ā9(5.05.Ā-964Ā଀Ā;6Ā\rĀ44\b"(73(9Ā9;0*(90(Ā0:Ā*/(9(*;,90A,+Ā)@Ā05;,5:,Ā7990;0:Ā(5+Ā:9965+05.Ā,9@;/,4(؀Ā6-;,5Ā79,*,+,+Ā)@Ā(Ā,(3Ā(;Ā;/,Ā:(4,Ā:0;,\bĀ%/,:,Ā3,:065:Ā-694Ā059,:765:,Ā;6Ā05:,*;Ā)0;,:Ā;/(;Ā*644653@Ā6**9Ā0567,5؀Ā,?76:,+Ā(9,(:\bĀĀĀĀĀĀᰀ47,;0.6Ā;@70*(33@Ā79,:,5;:Ā(:Ā,9@;/,4(;6:7(73,:ĀĀ0;/Ā/65,@Ā@,336ĀĀ*6369,+Ā*9:;05.؀*(:,+Ā)@Ā(Ā:7,9-0*0(3Ā\n଀Ā\bЀ\f؀܀Ȁ܀ȀȀԀ69Ā\n଀\t̀\b଀܀Ȁ܀ȀȀԀ:205Ā05-,*;065\bĀ%/,:,Ā7(73,:Ā6**9Ā46:;Ā-9,8,5;3@Ā65Ā,?76:,+Ā(9,(:Ā6-Ā;/,Ā)6+@Ā(5+Ā*(5Ā6**9(:Ā(Ā:,*65+(9@Ā*64730*(;065Ā6-Ā(;670*Ā+,94(;0;0:\bĀᤀ6?܀ᤀ69+@*,Ā+0:,(:,Ā0:Ā9(9,Ā05Ā79,7),9;(3Ā*/03+9,5Ā(5+Ā0:Ā(Ā*/9650*Ā7(73(9Ā,97;065Ā05Ā(76*905,.3(5+܀),(905.Ā(9,(:؀Ā:*/Ā(:Ā;/,Ā(?033(,؀Ā(5+Ā7,905,(3Ā9,.065:\bĀ%/,Ā7(73,:Ā(9,Ā:0403(9Ā05Ā(77,(9(5*,;6Ā4633:*4؀Ā);Ā,9@;/,4(Ā(5+Ā7990;0:Ā*(5Ā),469,Ā796565*,+\bĀĀĀ \rᜀᘀᨀ�؀ᬀ᠀ᬀ ᴀጀሀ�Ԁ ᤀᰀḀ \nကሀᄀ�܀ \f ᤀἀᰀ##ᰀ/଀&%Ḁ/ -/ᜀ/ᴀ %ᜀ#/5ᰀᜀ,/\fᰀᬀ ᤀᜀ#/ᄀ02ᬀᰀ%0/ᜀ0/0ἀᰀጀ% 3ᰀ,- 05/&ᴀ/ᄀᜀ-"ᜀ0ᤀἀᰀ4ᜀ%ᨀ/ᄀᜀ-"ᜀ0&&%ᨀ/Ā#᠀ᰀ,0ᜀ+܀ᜀ᠀, ᰀ#/\b2%Ḁ/ -/ᜀ/0ἀ ,ᬀ/5ᰀᜀ,/\fᰀᬀ ᤀᜀ#/ᄀ02ᬀᰀ%0/ᜀ0/0ἀᰀጀ% 3ᰀ,- 05/&ᴀ/Ȁ, 0 -ἀ/̀$᠀ ᜀᨀ/᐀ᜀ%ᤀ&23ᰀ,ᨀ/Ȁ, 0 -ἂ$᠀ ᜀ+\t&-ᰀ(ἀ/\f+/଀ᜀ$/ -/ᜀ/̀# % ᤀᜀ#/Ā-- -0ᜀ%0/ༀ,&ᴀᰀ--&,/&ᴀༀᰀᬀ ᜀ0, ᤀ-/ᜀ%ᬀ/Ā--&ᤀ ᜀ0ᰀ/\fᰀ$᠀ᰀ,/&ᴀ/0ἀᰀ/Ѐᰀ(ᜀ,0$ᰀ%0/&ᴀЀᰀ,$ᜀ0&#&Ḁ5/ᜀ%ᬀ/ᄀ" %/ᄀᤀ ᰀ%ᤀᰀ-/ᜀ0/0ἀᰀ/ጀ% 3ᰀ,- 05/&ᴀ/Ȁ, 0 -ἂ$᠀ ᜀ+/\bᰀ/(,ᜀᤀ0 ᤀᰀ-/ %/᐀ᜀ%ᤀ&23ᰀ,ᨀ/Ȁ, 0 -ἀ/̀$᠀ ᜀ+ ܀̀ሀἀᰀ/̀ᜀ%ᜀᬀ ᜀ%/\t&2,%ᜀ#/&ᴀ/̀\fԀ/./\fᜀ5/17'1 \f฀\r\tༀ\f ᐀Āༀ଀܀@,(9܀63+Ā4(3,Ā79,:,5;:ĀĀ0;/Ā43;073,Ā7(73,:Ā65;/,Ā5,*2؀Ā(?033(,؀Ā(5+Ā.9605؀ĀĀ/0*/Ā/(=,Ā),,5Ā43;073@05.Ā6=,9Ā;/,Ā@,(9:\b ༀᔀကἀ�ᘀḀ�#ᬀ ᴀ�ሀᘀက᐀ᨀᬀḀᘀḀ̀(\b ἀ633:*4Ā*65;(.06:4 )\b ᘀ64465ĀĀ(9;: *\b $,)699/,0*Ā2,9(;6:,: +\b ᐀*/96*69+65: ,\b ",+5*3(;,+Ā5,=0 ЀᨀḀ"ጀᴀ ᐀*/96*69+65:Ā69Ā:205Ā;(.:ĀĀ̀܀\t\n؀\b�ԀȀ(9,Ā*64465؀),50.5Ā/(5.05.Ā.96Ā;/:؀Ā*644653@Ā-65+Ā65Ā;/,Ā5,*2؀(9470;:؀Ā.9605؀Ā(5+Ā,@,30+:\bĀᔀ6;/Ā.,5+,9:Ā(9,Ā(--,*;,+؀(5+Ā;/,@Ā),*64,Ā05*9,(:05.3@Ā*64465ĀĀ0;/Ā(.,Ā(5+Ā,0./;Ā.(05\bĀ%/,@Ā(9,Ā7(9;0*3(9@Ā*64465Ā05Ā79,.5(5*@Ā(5+Ā6),:0;@؀Ā(5+Ā;/6:,ĀĀ0;/Ā;@7,Ā\fĀ+0(),;,:Ā4,330;:\bᘀ/(--05.\t9))05.؀Ā(5+Āᬀ"&Ā4(@Ā(3:6Ā73(@Ā(Ā963,\bĀ%/,@(9,Ā;@70*(33@Ā-3,:/܀*6369,+؀Ā;/6./Ā;/,@Ā*(5Ā(3:6Ā),+(92,9؀Ā(5+Ā;/,@Ā9(5.,Ā05Ā:0A,Ā-964Ā଀Ā;6Ā଀\nĀ44\b%9,(;4,5;Ā-69Ā*6:4,:0:Ā05*3+,:؀Ā,3,*;96:9.,9@؀3(:,9Ā()3(;065؀Ā:507Ā,?*0:065؀Ā(5+Ā*9@6;/,9(7@\b \tကᨀ᐀ᘀᨀ᐀�\rᜀᘀᨀ�\bᴀᬀ"ἀᔀḀ \nကሀᄀ�\b Ȁᰀ%!ᜀ$ %/Ȁᜀ,ᜀ%" %ᨀ/\fЀᨀ/؀က̀ༀ̀ᨀ/ -/ᜀ/Ѐᰀ,$ᜀ0&#&Ḁ -0(,ᜀᤀ0 ᤀ %Ḁ/ %/\r&,0ἀ/ᘀ&,"ᨀ/฀%0ᜀ, &+